By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


Company News
Kite Pharma (KITE) and Juno (JUNO)'s R&D Strategy to Reshape Cancer Treatment 6/21/2016 7:25:19 AM
Kite Pharma (KITE) Opens Up New T-Cell Therapy Manufacturing Plant in California 6/21/2016 6:26:57 AM
Kite Pharma (KITE) Expands Development Of T-Cell Receptor (TCR) Therapies Targeting HPV-Associated Cancers In Partnership With The NCI 6/20/2016 10:45:28 AM
Kite Pharma (KITE) To Highlight Key Data From CAR T-Cell Therapy Pipeline In Oral Presentations At The 2016 European Hematology Association Annual Congress 6/8/2016 8:19:05 AM
ASCO2016: Kite Pharma (KITE)/NCI Anti-CD19 CAR T-Cell Therapy Demonstrates Durable Complete Remissions In Advanced Non-Hodgkin Lymphoma 6/6/2016 9:23:17 AM
ASCO2016: Kite Pharma (KITE) Presents Ongoing Complete Responses At 9 Months In Phase I Of ZUMA-1 In Patients With Chemorefractory Non-Hodgkin Lymphoma 6/6/2016 9:21:04 AM
ASCO2016: Kite Pharma (KITE) Announces The First Meta-Analysis Of Outcomes In Chemorefractory Diffuse Large B-Cell Lymphoma (SCHOLAR-1) 6/6/2016 9:09:04 AM
Kite Pharma (KITE) Granted Access To Priority Medicines (PRIME) Regulatory Support For KTE-C19 In The Treatment Of Chemorefractory Diffuse Large B-Cell Lymphoma (DLBCL) 6/2/2016 11:19:06 AM
Kite Pharma (KITE) And Cell Design Labs Announce Exclusive Research Collaboration Using Molecular ‘On/Off Switches’ For CAR T-Cell Immunotherapies 6/2/2016 10:30:06 AM
ASCO2016: Kite Pharma (KITE) To Highlight Key Data From Engineered CAR T Cell Therapy Pipeline At The 2016 ASCO Annual Meeting 6/1/2016 4:28:50 PM